450
Views
46
CrossRef citations to date
0
Altmetric
Research Article

Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)/poly(lactic acid) microspheres for over 3 months

, , &
Pages 18-26 | Received 14 Dec 2007, Accepted 01 Apr 2008, Published online: 20 Oct 2008

References

  • Alvarez-Lorenzo C, Hiratani H, Gomez-Amoza JL, Martinez-Pacheco R, Souto C, Concheiro A. Soft contact lenses capable of sustained delivery of timolol. J Pharm Sci 2002; 91: 2182–2192
  • Alward WLM. Medical management of glaucoma. N Engl J Med 1998; 339: 1298–1307
  • Alward WLM. A new angle on ocular development. Science 2003; 299: 1527–1528
  • Alward WL, Feldman F, Cashwell LF, Wilensky J, Geijssen HC, Greeve E, Quigley H, Skuta G, Lichter PR, Blondeau P, Anderson DR, Grajewski A, Balazsi G, Amyot M, Levene RZ, Minckler D, Heuer D, Drance SM, Mikelberg F, Douglas G, Johnstone M, Trope G, Hoskins HD, Pollack IP, Mills R, Kasner OP, Schwartz A, Liebmann L, Ritch R, Cohen J, Tuulonen A, Airaksinen PJ, Collaborat Normal-Tens Glaucoma S. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998; 126: 498–505
  • Ayalasomayajula SP, Kompella UB. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat mode. Eur J Pharmacol 2005; 511: 191–198
  • Blomdahl S, Calissendorff BM, Tengroth B, Wallin O. Blindness in glaucoma patients. Acta Ophthalmol Scand 1997; 75: 589–591
  • Cui F, Cun DM, Tao AJ, Yang MS, Shi K, Zhao M, Guan Y. Preparation and characterization of melittin-loaded poly (DL-lactic acid) or poly (DL-lactic-co-glycolic acid) microspheres made by the double emulsion method. J Contr Rel 2005; 107: 310–319
  • Friedman DS, Wolfs RCW, O’Colmain B, Klein BE, Taylor HR, West S, Leske C, Mitchell P, Congdon N, Kempen J, Tielsch J. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004; 122: 532–538
  • Gilbert JA, Simpson AE, Rudnick DE, Geroski DH, Aaberg TM, Edelhauser HF. Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix. J Cont Rel 2003; 89: 409–417
  • Gurwitz JH, Glynn RJ, Monane M, Everitt DE, Gilden D, Smith N, Avorn J. Treatment for glaucoma – adherence by the elderly. Am J Public Health 1993; 83: 711–716
  • Hiratani H, Alvarez-Lorenzo C. Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. J Contr Rel 2002; 83: 223–230
  • Huang SF, Chen JL, Yeh MK, Chiang CH. Physicochemical properties and in vivo assessment of timolol-loaded poly(D,L-lactide-co-glycolide) films for long-term intraocular pressure lowering effects. J Ocular Pharmacol Therapeut 2005; 21: 445–453
  • Leske MC, Nemesure B, He Q, Wu SY, Hejtmancik JF, Hennis A. Patterns of open-angle glaucoma in the Barbados Family Study. Ophthalmology 2001; 108: 1015–1022
  • Li S. Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomed Mater Res 1999; 48: 342–353
  • Li SM, Garreau H, Vert M. Structure property relationships in the case of the degradation of massive poly(alpha-hydroxy acids) in aqueous-media. 2. Degradation of lactide-glycolide copolymers – Pla37.5ga25 and Pla75ga25. J Mater Sci-Mater Med 1990; 1: 131–139
  • Marquis RE, Whitson JT. Management of glaucoma: Focus on pharmacological therapy. Drugs Aging 2005; 22: 1–21
  • Mazzo DJ, Lopper AE. Timolol maleate. Analytical profiles of drug substances, K Florey. Academic Press, London 1987; 641–692
  • Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994; 101: 1651–1656
  • Mukesh BN, McCarty CA, Rait JL, Taylor HR. Five-year incidence of open-angle glaucoma – the visual impairment project. Ophthalmology 2002; 109: 1047–1051
  • Munier A, Gunning T, Kenny D, O’Keefe M. Causes of blindness in the adult population of the Republic of Ireland. Br J Ophthalmol 1998; 82: 630–633
  • Nihant N, Schugens C, Grandfils C, Jerome R, Teyssie P. Polylactide microparticles prepared by double emulsion-evaporation. 2. Effect of the poly(lactide-co-glycolide) composition on the stability of the primary and secondary emulsions. J Colloid Interf Sci 1995; 173: 55–65
  • Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres – effect of copolymer composition. Biomaterials 1995; 16: 1123–1130
  • Patrick M, Mitra AK. Overview of ocular drug delivery and iatrogenic ocular cytopathologies. Ophthalmic drug delivery systems, AK Mitra. Marcel Dekker, New York 1993; 1–27
  • Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389–393
  • Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye 1998; 12: 234–236
  • Sah HK, Toddywala R, Chien YW. The influence of biodegradable microcapsule formulations on the controlled-release of a protein. J Contr Rel 1994; 30: 201–211
  • Schoff EO, Hattenhauer MG, Ing HH, Hodge DO, Kennedy RH, Herman DC, Johnson DH. Estimated incidence of open-angle glaucoma in Olmsted County. Ophthalmology 2001; 108: 882–886
  • Schuman JS. Antiglaucoma medications: A review of safety and tolerability issues related to their use. Clin Therapeut 2000; 22: 167–208
  • Sezer AD, Akbuga J. Release characteristics of chitosan treated alginate beads: II. Sustained release of a low molecular drug from chitosan treated alginate beads. J Microencapsulation 1999; 16: 687–696
  • Shedden A, Laurence J, Tipping R. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: A six-month. Clin Therapeut 2001; 23: 440–450
  • Uusitalo H, Nino J, Tahvanainen K, Turjanmaa V, Ropo A, Tuominen J, Kahonen M. Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel. Acta Ophthalmol Scand 2005; 83: 723–728
  • Wang N, Qiu JS, Wu XS. Tailored polymeric materials for controlled delivery systems. ACS Symposium Series 709, I McCulloch, SW Shalaby. ACS, Washington, DC 1998; 242–254
  • Wilson RP, Kanal N, Spaeth GL. Timolol – its effectiveness in different types of glaucoma. Ophthalmology 1979; 86: 43–50
  • Worakul N, Robinson JR. Ocular pharmacokinetics/pharmacodynamics. Eur J Pharm Biopharm 1997; 44: 71–83
  • Yan CH, Resau JH, Hewetson J, West M, Rill WL, Kende M. Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in oil-in-water emulsion technique. J Contr Rel 1994; 32: 231–241
  • Zimmerman TJ, Kaufman HE. Beta-adrenergic blocking-agent for treatment of glaucoma. Arch Ophthalmol 1977; 95: 601–604

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.